Francis E. Odonnell Jr. - Chief Executive Officer, Director, 10%+ Owner at Inhibitor Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Executive Officer, Director, 10%+ Owner
Issuer ticker
INTI on OTC
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Francis E. Odonnell Jr. since 08 Sep 2025

Reported holdings for Francis E. Odonnell Jr. in Inhibitor Therapeutics, Inc.

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Inhibitor Therapeutics, Inc.

Security class
Common Stock
Shares / value
85,627,069
Estimated value
Report date
13 Dec 2022
Price
Ownership
Indirect
Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Inhibitor Therapeutics, Inc.

Security class
Common Stock
Shares / value
150,000
Estimated value
Report date
04 May 2026
Price
Ownership
Direct

Transaction history for Francis E. Odonnell Jr. in Inhibitor Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .